(19)
(11) EP 4 555 074 A1

(12)

(43) Date of publication:
21.05.2025 Bulletin 2025/21

(21) Application number: 23838376.4

(22) Date of filing: 14.07.2023
(51) International Patent Classification (IPC): 
C12N 7/00(2006.01)
C12N 7/02(2006.01)
C12N 7/01(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 31/519; A61K 35/766; C12N 2760/20032; C12N 2760/18432; C12N 2750/14143; C12N 2750/14152; C12N 2710/10332; A61K 31/428; A61K 31/7064
 
C-Sets:
A61K 35/766, A61K 2300/00;
(86) International application number:
PCT/CA2023/050955
(87) International publication number:
WO 2024/011332 (18.01.2024 Gazette 2024/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 14.07.2022 US 202263389064 P

(71) Applicant: Ottawa Hospital Research Institute
Ottawa, Ontario K1H 8L6 (CA)

(72) Inventors:
  • DIALLO, Jean-simon
    Ottawa, Ontario K1Z 5N4 (CA)
  • WONG, Boaz
    Concord, Ontario L4K 3K3 (CA)
  • BERGERON, Anabel
    Orleans, Ontario K1C 1B1 (CA)
  • ARULANANDAM, Rozanne
    Orleans, Ontario K1W 0B6 (CA)
  • MAZNYI, Glib Viktorovich
    Ottawa, Ontario K1V 9N5 (CA)

(74) Representative: Lewis Silkin LLP 
Arbor 255 Blackfriars Road
London SE1 9AX
London SE1 9AX (GB)

   


(54) NEDDYLATION-ACTIVATING ENZYME INHIBITORS AS VIRAL SENSITIZERS AND USES THEREOF